April 23, 2010

Vista Project I.D.: 32542

Mr. Kevin Donahoe

The Avogadro Group, LLC

3003 SW 153rd Drive

Suite 215

Beaverton, OR 97006

Dear Mr. Donahoe,

Enclosed are the results for the four MM5 samples received at Vista Analytical Laboratory on

March 30, 2010 under your Project Name "TransAlta Centralia". These samples were extracted

and analyzed using EPA Method 23 for tetra-through-octa chlorinated dioxins and furans and EPA

Method 1668 for PCB homologue totals and the World Health Organization's list of dioxin-like

PCB congeners. A standard turnaround time was provided for this work.

The PCB results flagged with an asterisk include a sample-specific detection limit in the "RL"

column. Detection limits were calculated for non-detected toxic congeners. All other congeners

are reported to the Reporting Limit (RL), which corresponds to the low-point in the initial

calibration curve.

The following report consists of a Sample Inventory (Section I), Analytical Results (Section II)

and the Appendix, which contains the chain-of-custody, a list of data qualifiers and abbreviations,

Vista's current certifications, and copies of the raw data (if requested).

Vista Analytical Laboratory is committed to serving you effectively. If you require additional

information, please contact me at 916-673-1520 or by email at mmaier@vista-analytical.com.

Thank you for choosing Vista as part of your analytical support team.

Sincerely,

Martha M. Maier

Laboratory Director

Vista Analytical Laboratory certifies that the report herein meets all the requirements set forth by NELAC for those applicable 

test methods. Results relate only to the samples as received by the laboratory. This report should not be reproduced except in full 

without the written approval of Vista Analytical Laboratory.

Project 32542 Page 1 of 26
Project No.:

Lab. Sample ID Client Sample ID 

 

32542

Project Name: TransAlta Centralia

3/30/2010

Section I: Sample Inventory Report

Date Received:

Component ID

001 1-PCDD-1 Fraction 1a- Filter

Fraction 1b-XAD

Fraction 2-Acetone, MeCl2

Fraction 3-Toluene

002 2-PCDD-1 Fraction 1a- Filter

Fraction 1b-XAD

Fraction 2-Acetone, MeCl2

Fraction 3-Toluene

003 3-PCDD-1 Fraction 1a- Filter

Fraction 1b-XAD

Fraction 2-Acetone, MeCl2

Fraction 3-Toluene

004 RB-PCDD-1 Fraction 1a- Filter

Fraction 1b-XAD

Fraction 2-Acetone, MeCl2

Fraction 3-Toluene

Smpinvgnmm5.rpt

Project 32542 Page 2 of 26
SECTION II

Project 32542 Page 3 of 26
Method Blank EPA Method 23

Matrix:

Sample Size:

QC Batch No.: Lab Sample:

Date Extracted:

MM5

Sample 7-Apr-10

0-MB001

Date Analyzed DB-5: 15-Apr-10 Date Analyzed DB-225: NA

2924

Analyte DL EMPC Qualifiers Labeled Standard %R LCL-UCL Qualifiers b d(pg/Sample) a Conc.

2,3,7,8-TCDD ND 5.16 IS 13C-2,3,7,8-TCDD 96.9 40 - 130

1,2,3,7,8-PeCDD ND 7.37 13C-1,2,3,7,8-PeCDD 98.1 40 - 130

1,2,3,4,7,8-HxCDD ND 11.4 13C-1,2,3,6,7,8-HxCDD 91.1 40 - 130

1,2,3,6,7,8-HxCDD ND 10.6 13C-1,2,3,4,6,7,8-HpCDD 82.8 25 - 130

1,2,3,7,8,9-HxCDD ND 10.4 13C-OCDD 80.7 25 - 130

1,2,3,4,6,7,8-HpCDD ND 13.3 13C-2,3,7,8-TCDF 93.4 40 - 130

OCDD ND 15.7 13C-1,2,3,7,8-PeCDF 95.0 40 - 130

2,3,7,8-TCDF ND 6.80 13C-1,2,3,6,7,8-HxCDF 81.6 40 - 130

1,2,3,7,8-PeCDF ND 10.5 13C-1,2,3,4,6,7,8-HpCDF 83.9 25 - 130

2,3,4,7,8-PeCDF ND 10.9 13C-OCDF 73.2 25 - 130

1,2,3,4,7,8-HxCDF ND 6.15 PS 37Cl-2,3,7,8-TCDD 95.1 70 - 130

1,2,3,6,7,8-HxCDF ND 5.78 13C-2,3,4,7,8-PeCDF 99.9 70 - 130

2,3,4,6,7,8-HxCDF ND 6.26 13C-1,2,3,4,7,8-HxCDD 99.9 70 - 130

1,2,3,7,8,9-HxCDF ND 7.36 13C-1,2,3,4,7,8-HxCDF 101 70 - 130

1,2,3,4,6,7,8-HpCDF ND 7.72 13C-1,2,3,4,7,8,9-HpCDF 90.5 70 - 130

1,2,3,4,7,8,9-HpCDF ND 9.31 AS 13C-1,2,3,7,8,9-HxCDF 82.6 40 - 130

OCDF ND 22.6

Totals Toxic Equivalent Quotient (TEQ) Data e

Total TCDD ND 5.15 TEQ (Min-Max): 0 - 22.9

Total PeCDD ND 7.37

Total HxCDD ND 10.8 a. Sample specific estimated detection limit.

Total HpCDD ND 13.3 b. Estimated maximum possible concentration.

Total TCDF ND 6.79 c. Method detection limit.

Total PeCDF ND 10.7 d. Lower control limit - upper control limit.

Total HxCDF ND 6.35 e. TEQ based on (2005) World Health Organization Toxic Equivalent Factors.(WHO)

Total HpCDF ND 8.46

Analyst: WJL Approved By: Martha M. Maier 16-Apr-2010 15:19

Project 32542 Page 4 of 26
OPR Results EPA Method 23

Matrix:

Sample Size: Sample

MM5 QC Batch No.: 2924

Date Extracted: 7-Apr-10

Lab Sample: 0-OPR001

Date Analyzed DB-5: 15-Apr-10 Date Analyzed DB-225: NA

Analyte Spike Conc. Conc. (ng/mL) OPR Limits Labeled Standard %R LCL-UCL Qualifier

2,3,7,8-TCDD 2.50 2.23 1.75 - 3.25 IS 13C-2,3,7,8-TCDD 95.8 40 - 130

1,2,3,7,8-PeCDD 12.5 11.1 8.75 - 16.3 13C-1,2,3,7,8-PeCDD 95.8 40 - 130

1,2,3,4,7,8-HxCDD 12.5 11.7 8.75 - 16.3 13C-1,2,3,6,7,8-HxCDD 85.8 40 - 130

1,2,3,6,7,8-HxCDD 12.5 12.0 8.75 - 16.3 13C-1,2,3,4,6,7,8-HpCDD 90.2 25 - 130

1,2,3,7,8,9-HxCDD 12.5 12.4 8.75 - 16.3 13C-OCDD 76.3 25 - 130

1,2,3,4,6,7,8-HpCDD 12.5 11.3 8.75 - 16.3 13C-2,3,7,8-TCDF 92.4 40 - 130

OCDD 25.0 22.8 17.5 - 32.5 13C-1,2,3,7,8-PeCDF 90.6 40 - 130

2,3,7,8-TCDF 2.50 2.26 1.75 - 3.25 13C-1,2,3,6,7,8-HxCDF 77.0 40 - 130

1,2,3,7,8-PeCDF 12.5 11.4 8.75 - 16.3 13C-1,2,3,4,6,7,8-HpCDF 81.9 25 - 130

2,3,4,7,8-PeCDF 12.5 12.1 8.75 - 16.3 13C-OCDF 74.1 25 - 130

1,2,3,4,7,8-HxCDF 12.5 12.3 8.75 - 16.3 AS 13C-1,2,3,7,8,9-HxCDF 78.8 40 - 130

1,2,3,6,7,8-HxCDF 12.5 13.0 8.75 - 16.3

2,3,4,6,7,8-HxCDF 12.5 12.6 8.75 - 16.3

1,2,3,7,8,9-HxCDF 12.5 12.2 8.75 - 16.3

1,2,3,4,6,7,8-HpCDF 12.5 11.8 8.75 - 16.3

1,2,3,4,7,8,9-HpCDF 12.5 11.2 8.75 - 16.3

OCDF 25.0 23.4 17.5 - 32.5

Analyst: WJL Approved By: Martha M. Maier 16-Apr-2010 15:19

Project 32542 Page 5 of 26
Sample ID: 1-PCDD-1 EPA Method 23

Client Data

Name:

Project:

Date Collected:

Sample Data

Matrix:

Sample Size:

Laboratory Data

Lab Sample:

QC Batch No.:

Date Received:

Date Extracted:

MM5 30-Mar-10

7-Apr-10 23-Mar-10 Sample

32542-001

TransAlta Centralia

Date Analyzed DB-5: 15-Apr-10 Date Analyzed DB-225: NA

The Avogadro Group, LLC

2924

Time Collected: NA

Analyte DL EMPC Qualifiers Labeled Standard %R LCL-UCL Qualifiers a b d Conc. (pg/Sample)

2,3,7,8-TCDD ND 7.39 IS 13C-2,3,7,8-TCDD 95.6 40 - 130

1,2,3,7,8-PeCDD ND 8.10 13C-1,2,3,7,8-PeCDD 95.4 40 - 130

1,2,3,4,7,8-HxCDD ND 12.5 13C-1,2,3,6,7,8-HxCDD 85.4 40 - 130

1,2,3,6,7,8-HxCDD ND 11.7 13C-1,2,3,4,6,7,8-HpCDD 88.6 25 - 130

1,2,3,7,8,9-HxCDD ND 11.4 13C-OCDD 81.8 25 - 130

1,2,3,4,6,7,8-HpCDD ND 10.5 13C-2,3,7,8-TCDF 92.8 40 - 130

OCDD ND 22.4 13C-1,2,3,7,8-PeCDF 96.5 40 - 130

2,3,7,8-TCDF ND 8.05 13C-1,2,3,6,7,8-HxCDF 82.1 40 - 130

1,2,3,7,8-PeCDF ND 9.75 13C-1,2,3,4,6,7,8-HpCDF 80.6 25 - 130

2,3,4,7,8-PeCDF ND 10.1 13C-OCDF 76.7 25 - 130

1,2,3,4,7,8-HxCDF ND 6.40 PS 37Cl-2,3,7,8-TCDD 94.7 70 - 130

1,2,3,6,7,8-HxCDF ND 6.01 13C-2,3,4,7,8-PeCDF 98.6 70 - 130

2,3,4,6,7,8-HxCDF ND 6.51 13C-1,2,3,4,7,8-HxCDD 98.9 70 - 130

1,2,3,7,8,9-HxCDF ND 7.66 13C-1,2,3,4,7,8-HxCDF 101 70 - 130

1,2,3,4,6,7,8-HpCDF ND 7.45 13C-1,2,3,4,7,8,9-HpCDF 98.9 70 - 130

1,2,3,4,7,8,9-HpCDF ND 8.99 AS 13C-1,2,3,7,8,9-HxCDF 82.2 40 - 130

OCDF ND 13.5

Totals Toxic Equivalent Quotient (TEQ) Data e

Total TCDD ND 7.41 TEQ (Min-Max): 0 - 26.1

Total PeCDD ND 8.10

Total HxCDD ND 11.9 a. Sample specific estimated detection limit.

Total HpCDD ND 10.5 b. Estimated maximum possible concentration.

Total TCDF ND 8.06 c. Method detection limit.

Total PeCDF ND 9.90 d. Lower control limit - upper control limit.

Total HxCDF ND 6.60 e. TEQ based on (2005) World Health Organization Toxic Equivalent Factors.(WHO)

Total HpCDF ND 8.15

Analyst: WJL Approved By: Martha M. Maier 16-Apr-2010 15:19

Project 32542 Page 6 of 26
Sample ID: 2-PCDD-1 EPA Method 23

Client Data

Name:

Project:

Date Collected:

Sample Data

Matrix:

Sample Size:

Laboratory Data

Lab Sample:

QC Batch No.:

Date Received:

Date Extracted:

MM5 30-Mar-10

7-Apr-10 24-Mar-10 Sample

32542-002

TransAlta Centralia

Date Analyzed DB-5: 15-Apr-10 Date Analyzed DB-225: NA

The Avogadro Group, LLC

2924

Time Collected: NA

Analyte DL EMPC Qualifiers Labeled Standard %R LCL-UCL Qualifiers a b d Conc. (pg/Sample)

2,3,7,8-TCDD ND 6.25 IS 13C-2,3,7,8-TCDD 96.7 40 - 130

1,2,3,7,8-PeCDD ND 8.66 13C-1,2,3,7,8-PeCDD 95.7 40 - 130

1,2,3,4,7,8-HxCDD ND 14.4 13C-1,2,3,6,7,8-HxCDD 90.8 40 - 130

1,2,3,6,7,8-HxCDD ND 13.4 13C-1,2,3,4,6,7,8-HpCDD 92.9 25 - 130

1,2,3,7,8,9-HxCDD ND 13.0 13C-OCDD 83.0 25 - 130

1,2,3,4,6,7,8-HpCDD ND 14.5 13C-2,3,7,8-TCDF 91.0 40 - 130

OCDD ND 27.0 13C-1,2,3,7,8-PeCDF 95.1 40 - 130

2,3,7,8-TCDF ND 7.50 13C-1,2,3,6,7,8-HxCDF 83.5 40 - 130

1,2,3,7,8-PeCDF ND 9.69 13C-1,2,3,4,6,7,8-HpCDF 86.7 25 - 130

2,3,4,7,8-PeCDF ND 10.0 13C-OCDF 77.9 25 - 130

1,2,3,4,7,8-HxCDF ND 4.87 PS 37Cl-2,3,7,8-TCDD 97.0 70 - 130

1,2,3,6,7,8-HxCDF ND 4.58 13C-2,3,4,7,8-PeCDF 99.3 70 - 130

2,3,4,6,7,8-HxCDF ND 4.96 13C-1,2,3,4,7,8-HxCDD 106 70 - 130

1,2,3,7,8,9-HxCDF ND 5.83 13C-1,2,3,4,7,8-HxCDF 102 70 - 130

1,2,3,4,6,7,8-HpCDF ND 8.23 13C-1,2,3,4,7,8,9-HpCDF 95.8 70 - 130

1,2,3,4,7,8,9-HpCDF ND 9.93 AS 13C-1,2,3,7,8,9-HxCDF 85.7 40 - 130

OCDF ND 25.0

Totals Toxic Equivalent Quotient (TEQ) Data e

Total TCDD ND 6.25 TEQ (Min-Max): 0 - 25.4

Total PeCDD ND 8.67

Total HxCDD ND 1.32 a. Sample specific estimated detection limit.

Total HpCDD ND 14.5 b. Estimated maximum possible concentration.

Total TCDF ND 7.50 c. Method detection limit.

Total PeCDF ND 9.85 d. Lower control limit - upper control limit.

Total HxCDF ND 5.01 e. TEQ based on (2005) World Health Organization Toxic Equivalent Factors.(WHO)

Total HpCDF ND 9.02

Analyst: WJL Approved By: Martha M. Maier 16-Apr-2010 15:19

Project 32542 Page 7 of 26
Sample ID: 3-PCDD-1 EPA Method 23

Client Data

Name:

Project:

Date Collected:

Sample Data

Matrix:

Sample Size:

Laboratory Data

Lab Sample:

QC Batch No.:

Date Received:

Date Extracted:

MM5 30-Mar-10

7-Apr-10 25-Mar-10 Sample

32542-003

TransAlta Centralia

Date Analyzed DB-5: 15-Apr-10 Date Analyzed DB-225: NA

The Avogadro Group, LLC

2924

Time Collected: NA

Analyte DL EMPC Qualifiers Labeled Standard %R LCL-UCL Qualifiers a b d Conc. (pg/Sample)

2,3,7,8-TCDD ND 9.29 IS 13C-2,3,7,8-TCDD 94.6 40 - 130

1,2,3,7,8-PeCDD ND 8.91 13C-1,2,3,7,8-PeCDD 98.0 40 - 130

1,2,3,4,7,8-HxCDD ND 16.6 13C-1,2,3,6,7,8-HxCDD 91.6 40 - 130

1,2,3,6,7,8-HxCDD ND 15.5 13C-1,2,3,4,6,7,8-HpCDD 89.8 25 - 130

1,2,3,7,8,9-HxCDD ND 15.1 13C-OCDD 82.1 25 - 130

1,2,3,4,6,7,8-HpCDD ND 8.76 13C-2,3,7,8-TCDF 93.7 40 - 130

OCDD ND 19.5 13C-1,2,3,7,8-PeCDF 95.9 40 - 130

2,3,7,8-TCDF ND 5.61 13C-1,2,3,6,7,8-HxCDF 84.7 40 - 130

1,2,3,7,8-PeCDF ND 6.80 13C-1,2,3,4,6,7,8-HpCDF 81.4 25 - 130

2,3,4,7,8-PeCDF ND 7.03 13C-OCDF 78.2 25 - 130

1,2,3,4,7,8-HxCDF ND 4.48 PS 37Cl-2,3,7,8-TCDD 96.1 70 - 130

1,2,3,6,7,8-HxCDF ND 4.21 13C-2,3,4,7,8-PeCDF 100 70 - 130

2,3,4,6,7,8-HxCDF ND 4.56 13C-1,2,3,4,7,8-HxCDD 105 70 - 130

1,2,3,7,8,9-HxCDF ND 5.37 13C-1,2,3,4,7,8-HxCDF 102 70 - 130

1,2,3,4,6,7,8-HpCDF ND 6.32 13C-1,2,3,4,7,8,9-HpCDF 103 70 - 130

1,2,3,4,7,8,9-HpCDF ND 7.62 AS 13C-1,2,3,7,8,9-HxCDF 83.9 40 - 130

OCDF ND 19.7

Totals Toxic Equivalent Quotient (TEQ) Data e

Total TCDD ND 9.30 TEQ (Min-Max): 0 - 27.9

Total PeCDD ND 8.92

Total HxCDD ND 15.7 a. Sample specific estimated detection limit.

Total HpCDD ND 8.76 b. Estimated maximum possible concentration.

Total TCDF ND 5.60 c. Method detection limit.

Total PeCDF ND 6.88 d. Lower control limit - upper control limit.

Total HxCDF ND 4.61 e. TEQ based on (2005) World Health Organization Toxic Equivalent Factors.(WHO)

Total HpCDF ND 6.91

Analyst: WJL Approved By: Martha M. Maier 16-Apr-2010 15:19

Project 32542 Page 8 of 26
Sample ID: RB-PCDD-1 EPA Method 23

Client Data

Name:

Project:

Date Collected:

Sample Data

Matrix:

Sample Size:

Laboratory Data

Lab Sample:

QC Batch No.:

Date Received:

Date Extracted:

MM5 30-Mar-10

7-Apr-10 22-Mar-10 Sample

32542-004

TransAlta Centralia

Date Analyzed DB-5: 15-Apr-10 Date Analyzed DB-225: NA

The Avogadro Group, LLC

2924

Time Collected: NA

Analyte DL EMPC Qualifiers Labeled Standard %R LCL-UCL Qualifiers a b d Conc. (pg/Sample)

2,3,7,8-TCDD ND 6.17 IS 13C-2,3,7,8-TCDD 92.5 40 - 130

1,2,3,7,8-PeCDD ND 6.51 13C-1,2,3,7,8-PeCDD 93.0 40 - 130

1,2,3,4,7,8-HxCDD ND 16.3 13C-1,2,3,6,7,8-HxCDD 87.2 40 - 130

1,2,3,6,7,8-HxCDD ND 15.2 13C-1,2,3,4,6,7,8-HpCDD 87.2 25 - 130

1,2,3,7,8,9-HxCDD ND 14.8 13C-OCDD 77.6 25 - 130

1,2,3,4,6,7,8-HpCDD ND 10.4 13C-2,3,7,8-TCDF 87.8 40 - 130

OCDD ND 11.4 13C-1,2,3,7,8-PeCDF 90.1 40 - 130

2,3,7,8-TCDF ND 5.61 13C-1,2,3,6,7,8-HxCDF 80.8 40 - 130

1,2,3,7,8-PeCDF ND 6.85 13C-1,2,3,4,6,7,8-HpCDF 81.1 25 - 130

2,3,4,7,8-PeCDF ND 7.07 13C-OCDF 78.4 25 - 130

1,2,3,4,7,8-HxCDF ND 2.70 PS 37Cl-2,3,7,8-TCDD 96.0 70 - 130

1,2,3,6,7,8-HxCDF ND 2.53 13C-2,3,4,7,8-PeCDF 100 70 - 130

2,3,4,6,7,8-HxCDF ND 2.74 13C-1,2,3,4,7,8-HxCDD 102 70 - 130

1,2,3,7,8,9-HxCDF ND 3.23 13C-1,2,3,4,7,8-HxCDF 102 70 - 130

1,2,3,4,6,7,8-HpCDF ND 4.03 13C-1,2,3,4,7,8,9-HpCDF 96.8 70 - 130

1,2,3,4,7,8,9-HpCDF ND 4.86 AS 13C-1,2,3,7,8,9-HxCDF 81.3 40 - 130

OCDF ND 22.3

Totals Toxic Equivalent Quotient (TEQ) Data e

Total TCDD ND 6.19 TEQ (Min-Max): 0 - 21.5

Total PeCDD ND 6.51

Total HxCDD ND 15.4 a. Sample specific estimated detection limit.

Total HpCDD ND 10.4 b. Estimated maximum possible concentration.

Total TCDF ND 5.62 c. Method detection limit.

Total PeCDF ND 6.95 d. Lower control limit - upper control limit.

Total HxCDF ND 2.78 e. TEQ based on (2005) World Health Organization Toxic Equivalent Factors.(WHO)

Total HpCDF ND 4.41

Analyst: WJL Approved By: Martha M. Maier 16-Apr-2010 15:19

Project 32542 Page 9 of 26
Matrix:

Sample Size:

QC Batch No.: Lab Sample:

Date Extracted:

MM5

Sample 7-Apr-10

2924 0-MB001

Analyte Conc. (ng/Sample) a Qualifiers Labeled Standard %R LCL-UCLb Qualifiers

Method Blank EPA Method 1668

Date Analyzed DB-1: 21-Apr-10

RL

PCB-77 ND 0.0837 * IS 13C-PCB-1 78.8 25 - 150

PCB-81 ND 0.0764 * 13C-PCB-3 81.0 25 - 150

PCB-105 ND 0.0804 * 13C-PCB-4 74.3 25 - 150

PCB-106/118 ND 0.0820 * 13C-PCB-9 78.9 25 - 150

PCB-114 ND 0.0837 * 13C-PCB-19 79.3 25 - 150

PCB-123 ND 0.0751 * 13C-PCB-28 79.9 25 - 150

PCB-126 ND 0.0889 * 13C-PCB-32 86.3 25 - 150

PCB-156 ND 0.0645 * 13C-PCB-37 90.4 25 - 150

PCB-157 ND 0.0731 * 13C-PCB-47 88.1 25 - 150

PCB-167 ND 0.0665 * 13C-PCB-81 97.0 25 - 150

PCB-169 ND 0.0759 * 13C-PCB-95 89.5 25 - 150

PCB-189 ND 0.0508 * 13C-PCB-97 91.5 25 - 150

13C-PCB-70 91.3 25 - 150

Total monoCB ND 0.100 13C-PCB-77 98.4 25 - 150

Total diCB ND 0.200 13C-PCB-80 92.2 25 - 150

Total triCB ND 0.100 13C-PCB-52 87.6 25 - 150

Total tetraCB ND 0.100 13C-PCB-54 88.5 25 - 150

Total pentaCB ND 0.100 13C-PCB-101 96.1 25 - 150

Total hexaCB ND 0.100 13C-PCB-104 96.8 25 - 150

Total heptaCB ND 0.100 13C-PCB-105 92.6 25 - 150

Total octaCB ND 0.100 13C-PCB-114 95.0 25 - 150

Total nonaCB ND 0.100 13C-PCB-118 98.5 25 - 150

Total decaCB ND 0.100 13C-PCB-123 105 25 - 150

Total PCB ND 0.200 13C-PCB-126 105 25 - 150

13C-PCB-127 100 25 - 150

13C-PCB-138 95.0 25 - 150

13C-PCB-141 97.3 25 - 150

13C-PCB-153 96.8 25 - 150

13C-PCB-155 114 25 - 150

Page 1 of 2

Project 32542 Page 10 of 26
Matrix:

Sample Size:

QC Batch No.: Lab Sample:

Date Extracted:

MM5

Sample 7-Apr-10

2924 0-MB001

Analyte Conc. (ng/Sample) a Qualifiers Labeled Standard %R LCL-UCLb Qualifiers

Method Blank EPA Method 1668

Date Analyzed DB-1: 21-Apr-10

RL

13C-PCB-156 102 25 - 150

13C-PCB-157 104 25 - 150

13C-PCB-159 99.4 25 - 150

13C-PCB-167 104 25 - 150

13C-PCB-169 112 25 - 150

13C-PCB-170 106 25 - 150

13C-PCB-180 109 25 - 150

13C-PCB-188 105 25 - 150

13C-PCB-189 118 25 - 150

13C-PCB-194 93.5 25 - 150

13C-PCB-202 115 25 - 150

13C-PCB-206 99.0 25 - 150

13C-PCB-208 109 25 - 150

13C-PCB-209 89.2 25 - 150

AS 13C-PCB-79 102 30 - 135

13C-PCB-178 96.3 30 - 135

TEQ (Min): 0

a. Reporting limit.

b. Lower control limit - upper control limit.

Analyst: WJL Page 2 of 2 Approved By: Martha M. Maier 23-Apr-2010 12:46

Project 32542 Page 11 of 26
OPR Results EPA Method 1668

Analyte Conc. (ng/mL) Labeled Standard %R LCL-UCL Qualifier

Matrix:

Sample Size:

QC Batch No.:

Date Extracted:

MM5

Sample 7-Apr-10

2924 Lab Sample: 0-OPR001

Spike Conc. OPR Limits

Date Analyzed DB-1: 21-Apr-10

PCB-77 50.0 44.8 25 - 75 IS 13C-PCB-1 82.3 25 - 150

PCB-81 50.0 45.3 25 - 75 13C-PCB-3 85.2 25 - 150

PCB-105 50.0 44.9 25 - 75 13C-PCB-4 73.7 25 - 150

PCB-106/118 100 85.4 50 - 150 13C-PCB-9 76.9 25 - 150

PCB-114 50.0 49.1 25 - 75 13C-PCB-19 78.7 25 - 150

PCB-123 50.0 39.6 25 - 75 13C-PCB-28 88.0 25 - 150

PCB-126 50.0 44.1 25 - 75 13C-PCB-32 86.3 25 - 150

PCB-156 50.0 45.6 25 - 75 13C-PCB-37 94.6 25 - 150

PCB-157 50.0 47.9 25 - 75 13C-PCB-47 95.1 25 - 150

PCB-167 50.0 46.0 25 - 75 13C-PCB-81 106 25 - 150

PCB-169 50.0 47.2 25 - 75 13C-PCB-95 95.2 25 - 150

PCB-189 50.0 43.3 25 - 75 13C-PCB-97 96.6 25 - 150

13C-PCB-70 102 25 - 150

13C-PCB-77 111 25 - 150

13C-PCB-80 103 25 - 150

13C-PCB-52 94.1 25 - 150

13C-PCB-54 92.5 25 - 150

13C-PCB-101 99.4 25 - 150

13C-PCB-104 95.9 25 - 150

13C-PCB-105 99.0 25 - 150

13C-PCB-114 101 25 - 150

13C-PCB-118 103 25 - 150

13C-PCB-123 108 25 - 150

13C-PCB-126 111 25 - 150

13C-PCB-127 104 25 - 150

13C-PCB-138 104 25 - 150

13C-PCB-141 108 25 - 150

13C-PCB-153 107 25 - 150

13C-PCB-155 117 25 - 150

13C-PCB-156 112 25 - 150

13C-PCB-157 110 25 - 150

13C-PCB-159 106 25 - 150

13C-PCB-167 111 25 - 150

13C-PCB-169 126 25 - 150

13C-PCB-170 114 25 - 150

13C-PCB-180 118 25 - 150

13C-PCB-188 112 25 - 150

13C-PCB-189 127 25 - 150

13C-PCB-194 97.0 25 - 150

Page 1 of 2 Approved by: Martha M. Maier 23-Apr-2010 12:46

Project 32542 Page 12 of 26
OPR Results EPA Method 1668

Analyte Conc. (ng/mL)

Matrix:

Sample Size:

QC Batch No.:

Date Extracted:

MM5

Sample 7-Apr-10

2924 Lab Sample: 0-OPR001

Spike Conc. OPR Limits

Date Analyzed DB-1: 21-Apr-10

13C-PCB-202 127 25 - 150

13C-PCB-206 111 25 - 150

13C-PCB-208 122 25 - 150

13C-PCB-209 98.8 25 - 150

Chemist: WJL Page 2 of 2 Approved by: Martha M. Maier 23-Apr-2010 12:46

Project 32542 Page 13 of 26
Matrix:

Sample Size:

Lab Sample:

QC Batch No.: Date Extracted:

MM5

Sample 7-Apr-10

32542-001

2924

Analyte Conc. (ng/Sample) RL

a

Qualifiers Labeled Standard %R LCL-UCL

b

Qualifiers

Sample ID: 1-PCDD-1 EPA Method 1668

Name:

Project:

Date Collected:

Time Collected:

The Avogadro Group, LLC Date Received:

TransAlta Centralia

NA

Client Data Sample Data Laboratory Data

30-Mar-10

23-Mar-10 Date Analyzed DB-1: 21-Apr-10

PCB-77 0.487 0.100 IS 13C-PCB-1 85.2 25 - 150

PCB-81 ND 0.0393 * 13C-PCB-3 84.0 25 - 150

PCB-105 15.3 0.100 13C-PCB-4 75.9 25 - 150

PCB-106/118 25.7 0.100 13C-PCB-9 80.8 25 - 150

PCB-114 1.10 0.100 13C-PCB-19 76.6 25 - 150

PCB-123 0.591 0.100 13C-PCB-28 89.7 25 - 150

PCB-126 ND 0.0667 * 13C-PCB-32 91.2 25 - 150

PCB-156 2.65 0.100 13C-PCB-37 108 25 - 150

PCB-157 0.740 0.100 13C-PCB-47 92.3 25 - 150

PCB-167 0.763 0.100 13C-PCB-81 111 25 - 150

PCB-169 ND 0.0488 * 13C-PCB-95 101 25 - 150

PCB-189 ND 0.0302 * 13C-PCB-97 107 25 - 150

13C-PCB-70 107 25 - 150

Total monoCB ND 0.100 13C-PCB-77 115 25 - 150

Total diCB ND 0.715 I 13C-PCB-80 107 25 - 150

Total triCB 1.61 0.100 13C-PCB-52 93.0 25 - 150

Total tetraCB 38.5 0.100 13C-PCB-54 87.8 25 - 150

Total pentaCB 105 0.100 13C-PCB-101 107 25 - 150

Total hexaCB 44.2 0.100 13C-PCB-104 101 25 - 150

Total heptaCB 4.18 0.100 13C-PCB-105 107 25 - 150

Total octaCB 0.257 0.100 13C-PCB-114 108 25 - 150

Total nonaCB ND 0.100 13C-PCB-118 114 25 - 150

Total decaCB ND 0.100 13C-PCB-123 120 25 - 150

Total PCB 189 0.200 13C-PCB-126 121 25 - 150

13C-PCB-127 114 25 - 150

13C-PCB-138 111 25 - 150

13C-PCB-141 110 25 - 150

Page 1 of 2

Project 32542 Page 14 of 26
Matrix:

Sample Size:

Lab Sample:

QC Batch No.: Date Extracted:

MM5

Sample 7-Apr-10

32542-001

2924

Analyte Conc. (ng/Sample) RL

a

Qualifiers Labeled Standard %R LCL-UCL

b

Qualifiers

Sample ID: 1-PCDD-1 EPA Method 1668

Name:

Project:

Date Collected:

Time Collected:

The Avogadro Group, LLC Date Received:

TransAlta Centralia

NA

Client Data Sample Data Laboratory Data

30-Mar-10

23-Mar-10 Date Analyzed DB-1: 21-Apr-10

13C-PCB-153 111 25 - 150

13C-PCB-155 123 25 - 150

13C-PCB-156 121 25 - 150

13C-PCB-157 122 25 - 150

13C-PCB-159 117 25 - 150

13C-PCB-167 124 25 - 150

13C-PCB-169 132 25 - 150

13C-PCB-170 122 25 - 150

13C-PCB-180 123 25 - 150

13C-PCB-188 117 25 - 150

13C-PCB-189 140 25 - 150

13C-PCB-194 110 25 - 150

13C-PCB-202 128 25 - 150

13C-PCB-206 112 25 - 150

13C-PCB-208 126 25 - 150

13C-PCB-209 104 25 - 150

AS 13C-PCB-79 103 30 - 135

13C-PCB-178 92.9 30 - 135

TEQ (Min): 0.00145

a. Reporting limit.

b. Lower control limit - upper control limit.

Analyst: WJL Page 2 of 2 Approved By: Martha M. Maier 23-Apr-2010 12:46

Project 32542 Page 15 of 26
Matrix:

Sample Size:

Lab Sample:

QC Batch No.: Date Extracted:

MM5

Sample 7-Apr-10

32542-002

2924

Analyte Conc. (ng/Sample) RL

a

Qualifiers Labeled Standard %R LCL-UCL

b

Qualifiers

Sample ID: 2-PCDD-1 EPA Method 1668

Name:

Project:

Date Collected:

Time Collected:

The Avogadro Group, LLC Date Received:

TransAlta Centralia

NA

Client Data Sample Data Laboratory Data

30-Mar-10

24-Mar-10 Date Analyzed DB-1: 21-Apr-10

PCB-77 0.363 0.100 IS 13C-PCB-1 73.9 25 - 150

PCB-81 0.254 0.100 13C-PCB-3 76.4 25 - 150

PCB-105 10.2 0.100 13C-PCB-4 68.3 25 - 150

PCB-106/118 17.7 0.100 13C-PCB-9 72.8 25 - 150

PCB-114 0.749 0.100 13C-PCB-19 71.9 25 - 150

PCB-123 0.362 0.100 13C-PCB-28 87.6 25 - 150

PCB-126 ND 0.0879 * 13C-PCB-32 78.9 25 - 150

PCB-156 1.73 0.100 13C-PCB-37 96.2 25 - 150

PCB-157 0.457 0.100 13C-PCB-47 80.9 25 - 150

PCB-167 0.518 0.100 13C-PCB-81 96.3 25 - 150

PCB-169 ND 0.0887 * 13C-PCB-95 87.6 25 - 150

PCB-189 ND 0.0438 * 13C-PCB-97 90.9 25 - 150

13C-PCB-70 93.3 25 - 150

Total monoCB ND 0.100 13C-PCB-77 102 25 - 150

Total diCB ND 0.570 I 13C-PCB-80 94.6 25 - 150

Total triCB 0.645 0.201 I 13C-PCB-52 81.1 25 - 150

Total tetraCB 29.2 0.100 13C-PCB-54 75.8 25 - 150

Total pentaCB 76.0 0.100 13C-PCB-101 92.4 25 - 150

Total hexaCB 29.9 0.100 13C-PCB-104 90.4 25 - 150

Total heptaCB 2.56 0.100 13C-PCB-105 96.5 25 - 150

Total octaCB ND 0.100 13C-PCB-114 97.2 25 - 150

Total nonaCB ND 0.100 13C-PCB-118 100 25 - 150

Total decaCB ND 0.100 13C-PCB-123 105 25 - 150

Total PCB 137 0.200 13C-PCB-126 111 25 - 150

13C-PCB-127 103 25 - 150

13C-PCB-138 95.0 25 - 150

13C-PCB-141 97.9 25 - 150

Page 1 of 2

Project 32542 Page 16 of 26
Matrix:

Sample Size:

Lab Sample:

QC Batch No.: Date Extracted:

MM5

Sample 7-Apr-10

32542-002

2924

Analyte Conc. (ng/Sample) RL

a

Qualifiers Labeled Standard %R LCL-UCL

b

Qualifiers

Sample ID: 2-PCDD-1 EPA Method 1668

Name:

Project:

Date Collected:

Time Collected:

The Avogadro Group, LLC Date Received:

TransAlta Centralia

NA

Client Data Sample Data Laboratory Data

30-Mar-10

24-Mar-10 Date Analyzed DB-1: 21-Apr-10

13C-PCB-153 99.4 25 - 150

13C-PCB-155 109 25 - 150

13C-PCB-156 105 25 - 150

13C-PCB-157 107 25 - 150

13C-PCB-159 104 25 - 150

13C-PCB-167 105 25 - 150

13C-PCB-169 120 25 - 150

13C-PCB-170 110 25 - 150

13C-PCB-180 108 25 - 150

13C-PCB-188 103 25 - 150

13C-PCB-189 118 25 - 150

13C-PCB-194 92.6 25 - 150

13C-PCB-202 115 25 - 150

13C-PCB-206 96.5 25 - 150

13C-PCB-208 106 25 - 150

13C-PCB-209 89.8 25 - 150

AS 13C-PCB-79 102 30 - 135

13C-PCB-178 97.2 30 - 135

TEQ (Min): 0.00106

a. Reporting limit.

b. Lower control limit - upper control limit.

Analyst: WJL Page 2 of 2 Approved By: Martha M. Maier 23-Apr-2010 12:46

Project 32542 Page 17 of 26
Matrix:

Sample Size:

Lab Sample:

QC Batch No.: Date Extracted:

MM5

Sample 7-Apr-10

32542-003

2924

Analyte Conc. (ng/Sample) RL

a

Qualifiers Labeled Standard %R LCL-UCL

b

Qualifiers

Sample ID: 3-PCDD-1 EPA Method 1668

Name:

Project:

Date Collected:

Time Collected:

The Avogadro Group, LLC Date Received:

TransAlta Centralia

NA

Client Data Sample Data Laboratory Data

30-Mar-10

25-Mar-10 Date Analyzed DB-1: 21-Apr-10

PCB-77 0.676 0.100 IS 13C-PCB-1 79.2 25 - 150

PCB-81 ND 0.0391 * 13C-PCB-3 79.0 25 - 150

PCB-105 23.4 0.100 13C-PCB-4 72.0 25 - 150

PCB-106/118 40.0 0.100 13C-PCB-9 78.8 25 - 150

PCB-114 1.68 0.100 13C-PCB-19 75.6 25 - 150

PCB-123 0.898 0.100 13C-PCB-28 87.9 25 - 150

PCB-126 0.169 0.100 13C-PCB-32 83.2 25 - 150

PCB-156 3.79 0.100 13C-PCB-37 101 25 - 150

PCB-157 1.09 0.100 13C-PCB-47 88.9 25 - 150

PCB-167 1.16 0.100 13C-PCB-81 105 25 - 150

PCB-169 ND 0.0400 * 13C-PCB-95 90.8 25 - 150

PCB-189 ND 0.0306 * 13C-PCB-97 97.2 25 - 150

13C-PCB-70 101 25 - 150

Total monoCB ND 0.100 13C-PCB-77 107 25 - 150

Total diCB ND 0.626 I 13C-PCB-80 102 25 - 150

Total triCB 1.61 0.100 13C-PCB-52 89.7 25 - 150

Total tetraCB 63.9 0.100 13C-PCB-54 85.4 25 - 150

Total pentaCB 172 0.100 13C-PCB-101 95.8 25 - 150

Total hexaCB 66.6 0.175 I 13C-PCB-104 94.4 25 - 150

Total heptaCB 5.67 0.100 13C-PCB-105 101 25 - 150

Total octaCB 0.302 0.135 I 13C-PCB-114 100 25 - 150

Total nonaCB ND 0.100 13C-PCB-118 104 25 - 150

Total decaCB ND 0.100 13C-PCB-123 108 25 - 150

Total PCB 308 0.200 13C-PCB-126 116 25 - 150

13C-PCB-127 110 25 - 150

13C-PCB-138 101 25 - 150

13C-PCB-141 102 25 - 150

Page 1 of 2

Project 32542 Page 18 of 26
Matrix:

Sample Size:

Lab Sample:

QC Batch No.: Date Extracted:

MM5

Sample 7-Apr-10

32542-003

2924

Analyte Conc. (ng/Sample) RL

a

Qualifiers Labeled Standard %R LCL-UCL

b

Qualifiers

Sample ID: 3-PCDD-1 EPA Method 1668

Name:

Project:

Date Collected:

Time Collected:

The Avogadro Group, LLC Date Received:

TransAlta Centralia

NA

Client Data Sample Data Laboratory Data

30-Mar-10

25-Mar-10 Date Analyzed DB-1: 21-Apr-10

13C-PCB-153 103 25 - 150

13C-PCB-155 113 25 - 150

13C-PCB-156 111 25 - 150

13C-PCB-157 111 25 - 150

13C-PCB-159 108 25 - 150

13C-PCB-167 112 25 - 150

13C-PCB-169 126 25 - 150

13C-PCB-170 113 25 - 150

13C-PCB-180 115 25 - 150

13C-PCB-188 108 25 - 150

13C-PCB-189 127 25 - 150

13C-PCB-194 102 25 - 150

13C-PCB-202 120 25 - 150

13C-PCB-206 105 25 - 150

13C-PCB-208 115 25 - 150

13C-PCB-209 97.2 25 - 150

AS 13C-PCB-79 100 30 - 135

13C-PCB-178 94.0 30 - 135

TEQ (Min): 0.0191

a. Reporting limit.

b. Lower control limit - upper control limit.

Analyst: WJL Page 2 of 2 Approved By: Martha M. Maier 23-Apr-2010 12:46

Project 32542 Page 19 of 26
Matrix:

Sample Size:

Lab Sample:

QC Batch No.: Date Extracted:

MM5

Sample 7-Apr-10

32542-004

2924

Analyte Conc. (ng/Sample) RL

a

Qualifiers Labeled Standard %R LCL-UCL

b

Qualifiers

Sample ID: RB-PCDD-1 EPA Method 1668

Name:

Project:

Date Collected:

Time Collected:

The Avogadro Group, LLC Date Received:

TransAlta Centralia

NA

Client Data Sample Data Laboratory Data

30-Mar-10

22-Mar-10 Date Analyzed DB-1: 21-Apr-10

PCB-77 ND 0.0501 * IS 13C-PCB-1 76.5 25 - 150

PCB-81 ND 0.0451 * 13C-PCB-3 76.2 25 - 150

PCB-105 1.73 0.100 13C-PCB-4 70.2 25 - 150

PCB-106/118 2.83 0.100 13C-PCB-9 73.9 25 - 150

PCB-114 ND 0.0954 * 13C-PCB-19 74.2 25 - 150

PCB-123 ND 0.0978 * 13C-PCB-28 85.3 25 - 150

PCB-126 ND 0.116 * 13C-PCB-32 83.0 25 - 150

PCB-156 0.312 0.100 13C-PCB-37 93.0 25 - 150

PCB-157 ND 0.0767 * 13C-PCB-47 90.0 25 - 150

PCB-167 ND 0.0704 * 13C-PCB-81 105 25 - 150

PCB-169 ND 0.0884 * 13C-PCB-95 92.0 25 - 150

PCB-189 ND 0.0520 * 13C-PCB-97 94.4 25 - 150

13C-PCB-70 98.3 25 - 150

Total monoCB ND 0.100 13C-PCB-77 109 25 - 150

Total diCB ND 0.200 13C-PCB-80 98.0 25 - 150

Total triCB ND 0.100 13C-PCB-52 88.9 25 - 150

Total tetraCB 4.34 0.100 13C-PCB-54 84.4 25 - 150

Total pentaCB 11.2 0.100 13C-PCB-101 94.0 25 - 150

Total hexaCB 3.70 0.100 13C-PCB-104 93.2 25 - 150

Total heptaCB 0.173 0.111 I 13C-PCB-105 101 25 - 150

Total octaCB ND 0.100 13C-PCB-114 100 25 - 150

Total nonaCB ND 0.100 13C-PCB-118 100 25 - 150

Total decaCB ND 0.100 13C-PCB-123 109 25 - 150

Total PCB 20.6 0.200 13C-PCB-126 110 25 - 150

13C-PCB-127 109 25 - 150

13C-PCB-138 102 25 - 150

13C-PCB-141 102 25 - 150

Page 1 of 2

Project 32542 Page 20 of 26
Matrix:

Sample Size:

Lab Sample:

QC Batch No.: Date Extracted:

MM5

Sample 7-Apr-10

32542-004

2924

Analyte Conc. (ng/Sample) RL

a

Qualifiers Labeled Standard %R LCL-UCL

b

Qualifiers

Sample ID: RB-PCDD-1 EPA Method 1668

Name:

Project:

Date Collected:

Time Collected:

The Avogadro Group, LLC Date Received:

TransAlta Centralia

NA

Client Data Sample Data Laboratory Data

30-Mar-10

22-Mar-10 Date Analyzed DB-1: 21-Apr-10

13C-PCB-153 105 25 - 150

13C-PCB-155 112 25 - 150

13C-PCB-156 110 25 - 150

13C-PCB-157 109 25 - 150

13C-PCB-159 104 25 - 150

13C-PCB-167 113 25 - 150

13C-PCB-169 120 25 - 150

13C-PCB-170 109 25 - 150

13C-PCB-180 110 25 - 150

13C-PCB-188 110 25 - 150

13C-PCB-189 117 25 - 150

13C-PCB-194 103 25 - 150

13C-PCB-202 118 25 - 150

13C-PCB-206 109 25 - 150

13C-PCB-208 124 25 - 150

13C-PCB-209 98.8 25 - 150

AS 13C-PCB-79 99.0 30 - 135

13C-PCB-178 99.5 30 - 135

TEQ (Min): 0.000146

a. Reporting limit.

b. Lower control limit - upper control limit.

Analyst: WJL Page 2 of 2 Approved By: Martha M. Maier 23-Apr-2010 12:46

Project 32542 Page 21 of 26
APPENDIX

Project 32542 Page 22 of 26
DATA QUALIFIERS & ABBREVIATIONS 

 

B This compound was also detected in the method blank. 

 D Dilution 

 E The amount detected is above the High Calibration Limit. 

 P The amount reported is the maximum possible concentration due to possible 

chlorinated diphenylether interference. 

 H Recovery was outside laboratory acceptance limits. 

 I Chemical Interference 

 J The amount detected is below the Low Calibration Limit. 

 

 * See Cover Letter 

 Conc. Concentration 

 DL Sample-specific estimated detection limit 

 MDL The minimum concentration of a substance that can be measured and 

reported with 99% confidence that the analyte concentration is greater 

than zero in the matrix tested. 

 EMPC Estimated Maximum Possible Concentration 

 NA Not applicable 

 

 RL Reporting Limit – concentrations that correspond to low calibration point 

 ND Not Detected 

 TEQ Toxic Equivalency 

 

Unless otherwise noted, solid sample results are reported in dry weight. Tissue samples are reported 

in wet weight. 

 

Project 32542 Page 23 of 26
CERTIFICATIONS

Accrediting Authority Certificate Number 

State of Alaska, DEC CA413-2008 

State of Arizona AZ0639 

State of Arkansas, DEQ 08-043-0 

State of Arkansas, DOH Reciprocity through CA 

State of California – NELAP Primary AA 02102CA 

State of Colorado N/A 

State of Connecticut PH-0182 

State of Florida, DEP E87777 

State of Indiana Department of Health C-CA-02 

Commonwealth of Kentucky 90063 

State of Louisiana, Health and Hospitals LA08000 

State of Louisiana, DEQ 01977 

State of Maine 2008024 

State of Michigan 9932 

State of Mississippi Reciprocity through CA 

Naval Facilities Engineering Service Center NFESC413 

State of Nevada CA004132007A 

State of New Jersey CA003 

State of New Mexico Reciprocity through CA 

State of New York, DOH 11411 

State of North Carolina 06700 

State of North Dakota, DOH R-078 

State of Oklahoma D9919 

State of Oregon CA200001-006 

State of Pennsylvania 68-00490 

State of South Carolina 87002001 

State of Tennessee TN02996 

State of Texas T104704189-08-TX 

U.S. Army Corps of Engineers N/A 

State of Utah CA16400 

Commonwealth of Virginia 00013 

State of Washington C1285 

State of Wisconsin 998036160 

State of Wyoming 8TMS-Q 

Project 32542 Page 24 of 26
Project 32542 
Project 32542 Page 26 of 26